Genicon

About Genicon

Genicon, founded in 1998, is a privately held company specializing in the design, manufacturing, and distribution of surgical instrumentation for laparoscopic procedures. Based in the Orlando, Florida area, the firm operates in the minimally invasive surgery (MIS) market, which serves various medical fields including general surgery, gynecology, urology, and pediatric surgery. The company's business model centers on developing and selling patented, US-made surgical instruments that aim to provide cost-effective solutions for healthcare providers without compromising on patient outcomes. Genicon's revenue is generated through the sale of its product lines to a global market, spanning over 48 countries. Its client base consists of surgeons and healthcare administrators in hospitals and surgical centers.

The company's product portfolio is extensive, featuring families of laparoscopic instruments that are both disposable and of limited life. Key product categories include trocar and cannula systems, such as the bladeless GeniLook and GeniPort, and the shielded blade GeniShield. Genicon also produces mono-polar and bi-polar instrumentation, lavage and ligation systems, Veress needles, and specimen retrieval bags. These instruments have received FDA approval and are CE marked for distribution within the European Union. The company has engaged in multiple funding rounds to support its operations and growth, securing a total of $7.6 million over seven rounds, including a Series B and several venture debt financings with investors like Advantage Capital and Rand Capital.

Genicon positions itself by addressing the dual needs of the modern healthcare system: clinical performance and economic efficiency. The instruments are designed for use in common minimally invasive procedures like gallbladder removals and gastric banding. The company has pursued international expansion to increase its sales and profit margins, identifying Europe as a key initial market before targeting other regions. While specific founder details are not prominently available, the firm notes that several of its shareholders are surgeons who actively use its products, providing direct clinical feedback into the development process.